Financhill
Back

MoonLake Immunotherapeutics Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
77

MLTX
MoonLake Immunotherapeutics

Last Price:
54.25
Seasonality Move:
43.17%
Sell
45

CRSP
CRISPR Therapeutics AG

Last Price:
47.89
Seasonality Move:
12.87%
Buy
77
MoonLake Immunotherapeutics (MLTX) is a Buy

Is MoonLake Immunotherapeutics a Buy, Sell or Hold?

  • The current MoonLake Immunotherapeutics [MLTX] share price is $54.32. The Score for MLTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • MLTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $47.88. The Score for CRSP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MLTX Stock Price Chart

What is MoonLake Immunotherapeutics's stock price today?

  • The MoonLake Immunotherapeutics share price today is $54.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $47.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

MLTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.75 Buy
Relative Strength Index (14 RSI): 61.92 Buy
Chaikin Money Flow: 145628 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.9 - 51.74) Buy
Bollinger Bands (100): (44.84 - 51.3) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 48.07 Sell
Chaikin Money Flow: 1329489 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.76 - 51) Sell
Bollinger Bands (100): (45.56 - 53.76) Sell

MLTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.78 Buy
20-day SMA: 49.82 Buy
50-day SMA: 50.11 Buy
200-day SMA: 46.83 Buy
8-day EMA: 51.25 Buy
20-day EMA: 50.32 Buy
50-day EMA: 49.44 Buy
200-day EMA: 47.33 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.45 Buy
20-day SMA: 49.2 Sell
50-day SMA: 47.99 Sell
200-day SMA: 57.15 Sell
8-day EMA: 47.81 Buy
20-day EMA: 48.44 Sell
50-day EMA: 48.6 Sell
200-day EMA: 53.27 Sell

MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and a decrease next year of $0.72 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.

MoonLake Immunotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):